Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib Trial of eRapa in Prostate Cancer Under Active Surveillance
NCT03618355Phase 1Completed
- Sponsor
- Emtora Biosciences
- Start
- Aug 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sirolimus in prostate cancer (PCa) (4 arms), sponsored by Emtora Biosciences. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 1 year. Started Aug 2018; status: completed.
02
Drugs
sirolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03618355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03618355.